Connection

Co-Authors

This is a "connection" page, showing publications co-authored by RANDAL S WEBER and STEPHEN YENZEN LAI.
Connection Strength

2.424
  1. High-risk non-melanoma skin cancer of the head and neck. Curr Oncol Rep. 2005 Mar; 7(2):154-8.
    View in: PubMed
    Score: 0.265
  2. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg. 2002 May; 128(5):521-6.
    View in: PubMed
    Score: 0.218
  3. Ultra-small superparamagnetic iron oxide (USPIO) magnetic resonance imaging in benign mixed tumor of the parotid gland. Clin Case Rep. 2021 Jan; 9(1):123-127.
    View in: PubMed
    Score: 0.198
  4. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
    View in: PubMed
    Score: 0.191
  5. Incompletely treated malignancies of the major salivary gland: Toward evidence-based care. Head Neck. 2018 08; 40(8):1630-1638.
    View in: PubMed
    Score: 0.165
  6. Development and Feasibility of a Specialty-Specific National Surgical Quality Improvement Program (NSQIP): The Head and Neck-Reconstructive Surgery NSQIP. JAMA Otolaryngol Head Neck Surg. 2016 Apr; 142(4):321-7.
    View in: PubMed
    Score: 0.143
  7. Improving patient outcomes through multidisciplinary treatment planning conference. Head Neck. 2016 04; 38 Suppl 1:E1820-5.
    View in: PubMed
    Score: 0.140
  8. An audit and feedback system for effective quality improvement in head and neck surgery: Can we become better surgeons? Cancer. 2015 May 15; 121(10):1581-7.
    View in: PubMed
    Score: 0.132
  9. Quality and performance indicators in an academic department of head and neck surgery. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1212-8.
    View in: PubMed
    Score: 0.099
  10. Head and neck cancer: an evolving treatment paradigm. Cancer. 2008 Oct 01; 113(7 Suppl):1911-32.
    View in: PubMed
    Score: 0.085
  11. Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma. Surg Oncol. 2022 Sep; 44:101804.
    View in: PubMed
    Score: 0.055
  12. Outcomes after definitive surgery for mandibular osteoradionecrosis. Head Neck. 2022 06; 44(6):1313-1323.
    View in: PubMed
    Score: 0.054
  13. Clinical care pathway for head and neck cancer: a valuable tool for decreasing resource utilization. Arch Otolaryngol Head Neck Surg. 2002 Mar; 128(3):258-62.
    View in: PubMed
    Score: 0.054
  14. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019 06 01; 125(11):1823-1829.
    View in: PubMed
    Score: 0.044
  15. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Laryngoscope. 2020 01; 130(1):146-153.
    View in: PubMed
    Score: 0.044
  16. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1941.
    View in: PubMed
    Score: 0.043
  17. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1942.
    View in: PubMed
    Score: 0.043
  18. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654.
    View in: PubMed
    Score: 0.043
  19. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. 2018 09; 40(9):2060-2069.
    View in: PubMed
    Score: 0.041
  20. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol. 2018 04; 79:1-8.
    View in: PubMed
    Score: 0.041
  21. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 11 23; 12(1):186.
    View in: PubMed
    Score: 0.040
  22. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
    View in: PubMed
    Score: 0.040
  23. Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades. Dysphagia. 2018 04; 33(2):185-191.
    View in: PubMed
    Score: 0.039
  24. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck. 2017 08; 39(8):1609-1620.
    View in: PubMed
    Score: 0.039
  25. Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation. Cancer. 2017 Jan 01; 123(1):62-70.
    View in: PubMed
    Score: 0.037
  26. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016 12; 38(12):1739-1751.
    View in: PubMed
    Score: 0.037
  27. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck. 2016 04; 38 Suppl 1:E1962-8.
    View in: PubMed
    Score: 0.035
  28. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 Dec 15; 20(24):6582-92.
    View in: PubMed
    Score: 0.032
  29. Research education and training in otolaryngology: meeting summary and research opportunities. Otolaryngol Head Neck Surg. 2006 Sep; 135(3):361-7.
    View in: PubMed
    Score: 0.018
  30. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995 Jun 22; 64(3):196-201.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.